MM

Merit Medical Systems IncNASDAQ MMSI Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Dec, 2024

Last price

Market cap $B

5.798

Middle

Exchange

XNAS - Nasdaq

MMSI Stock Analysis

MM

Neutral

Based on Eyestock quantitative analysis, MMSI`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

71/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

12.0 %

Undervalued

Market cap $B

5.798

Dividend yield

Shares outstanding

57.318 B

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,846 full-time employees. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. The company offers products in five product categories: peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer (OEM) and endoscopy.

View Section: Eyestock Rating